OHSU’s Ongoing Efforts in the Fight Against COVID-19: Updates, Initiatives, and Impact

As of Thursday, Sept. 29, 2022, the situation regarding COVID-19 hospitalizations is as follows:

  • OHSU is currently treating 16 patients, while Hillsboro Medical Center has 2 patients under their care.

Here are the hospitalization details for OHSU Hospital and OHSU Health Hillsboro Medical Center:

  • 8 patients are not fully vaccinated.
  • 10 patients are fully vaccinated.
  • None of the fully vaccinated patients have received a booster shot.
  • 1 patient has been discharged.
  • There are currently 17 infectious cases.

In the ICU, there are 5 patients:

  • 3 patients are not fully vaccinated.
  • 2 patients are fully vaccinated.
  • None of the fully vaccinated patients have received a booster shot.

Among the patients on ventilators, there are 3 cases:

  • 3 patients are not fully vaccinated.
  • None of the fully vaccinated patients have received a booster shot.

Adventist Health Portland is treating 3 patients.

Since Feb. 28, 2020, there have been 260,442 patients tested at OHSU. Of these, 28,407 COVID-19 cases have been confirmed, with 16 patients currently hospitalized and 200 patients awaiting test results. Unfortunately, there have been 208 in-hospital deaths.

In the most recent update, 9 new patient cases were detected since Sept. 28.

OHSU has conducted 45,421 COVID-19 tests for 14,090 staff and students. Of these tests, 4,595 have detected COVID-19 in 3,778 staff and students, while 40,372 tests for 12,552 individuals have resulted in negative findings. Currently, 315 tests are pending.

In terms of community vaccinations, OHSU has administered 454,506 vaccine doses through its vaccination sites. Additionally, the joint efforts of OHSU, Legacy Health, Kaiser Permanente, and Providence Health & Services have led to the administration of 546,166 vaccine doses at the Oregon Convention Center vaccination site. More information about community locations and eligibility can be found on the OHSU COVID-19 Vaccines website.

As the state’s academic health center, Oregon Health & Science University continues to work closely with state and local public health authorities and health systems in the metro area to coordinate a regional response to the ongoing COVID-19 pandemic. OHSU’s focus remains on containing the spread of the virus, primarily through vaccination efforts that commenced on Dec. 15, 2020.

OHSU has established various measures and protocols to handle the surge of COVID-19 cases while actively working to contain the spread of the SARS-CoV-2 virus and protect its workforce.

The institution continues to encourage the use of face masks, both for patients and staff within the hospital. OHSU’s dedicated research community has been instrumental in various endeavors, including the establishment of an in-house COVID-19 testing lab, extensive vaccination programs, and research initiatives aimed at understanding the immune response to COVID-19.

Efforts are also being made to ensure access to COVID-19 testing and appropriate healthcare for all Oregonians, particularly those from communities most impacted by the pandemic. OHSU has expanded its testing capabilities and introduced new initiatives such as free testing at its rapid care clinics.

OHSU remains committed to providing comprehensive care to patients, addressing the challenges brought on by the COVID-19 pandemic, and supporting its workforce through various wellness programs and initiatives. The university has implemented measures such as the option for remote work and the provision of childcare accommodations to support its staff during these challenging times.

Through its ongoing research and collaborative efforts, OHSU aims to contribute significantly to the scientific understanding of the novel coronavirus and play a key role in bringing the pandemic under control.

Overall, OHSU’s continued dedication to healthcare, research, and community outreach underscores its commitment to addressing the multifaceted challenges posed by the ongoing COVID-19 pandemic.

Leave a Reply